EXOZYMES INC.

EXOZ · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
31
SEC Filings

Business Summary

PART I Overview Chemicals are ubiquitous in modern life - they form the basis of medicines, fuels, plastics, food, and colors, among many other applications that together contribute to our ability to live the good life in the modern world. Harvesting chemicals from nature via traditional extraction methods is often inefficient and often requires large amounts of biological material to extract the necessary amounts of the desired chemical compounds. So, despite maybe being sustainable, it is not ...

Next Earnings

Q2 FY2026 — expected 2026-07-17

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionEXOZdiscussed_in_filing Artificial Intelligence
topic_mentionEXOZdiscussed_in_filing Cybersecurity
topic_mentionEXOZdiscussed_in_filing Trusted Computing
topic_mentionEXOZdiscussed_in_filing Blockchain & Crypto
topic_mentionEXOZdiscussed_in_filing Capital Expenditure
topic_mentionEXOZdiscussed_in_filing Regulation
topic_mentionEXOZdiscussed_in_filing Healthcare & Bio
topic_mentionEXOZdiscussed_in_filing Platform & Ecosystem
topic_mentionEXOZdiscussed_in_filing Sovereign & Government
topic_mentionEXOZdiscussed_in_filing Artificial Intelligence
topic_mentionEXOZdiscussed_in_filing Cybersecurity
topic_mentionEXOZdiscussed_in_filing Trusted Computing
topic_mentionEXOZdiscussed_in_filing Blockchain & Crypto
topic_mentionEXOZdiscussed_in_filing Capital Expenditure
topic_mentionEXOZdiscussed_in_filing Regulation
topic_mentionEXOZdiscussed_in_filing Healthcare & Bio
topic_mentionEXOZdiscussed_in_filing Platform & Ecosystem
topic_mentionEXOZdiscussed_in_filing Sovereign & Government
topic_mentionEXOZdiscussed_in_filing Artificial Intelligence
topic_mentionEXOZdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001493152-26-013563EDGAR54K words
2025-03-312024-12-310001641172-25-001744EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001493152-25-022289EDGAR20K words
2025-08-122025-06-300001641172-25-023184EDGAR—
2025-05-122025-03-310001641172-25-009636EDGAR—
2024-11-122024-09-300001493152-24-044813EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001493152-26-013733EDGAR0K words
2026-02-050001493152-26-005176EDGAR—
2025-12-120001493152-25-027327EDGAR—
2025-11-130001493152-25-022295EDGAR—
2025-10-030001493152-25-016831EDGAR—
2025-07-280001641172-25-021084EDGAR—
2025-07-080001641172-25-018053EDGAR—
2025-06-260001641172-25-016681EDGAR—
2025-06-200001641172-25-015782EDGAR—
2025-04-020001641172-25-002396EDGAR—

31 total filings indexed. 15 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0002010788
TickerEXOZ
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 698c8345d39aecc7140e398869a47abd295b5123f2172f685f9ac3ab0dea01a7
parent: f5110d13ecbfc1e88c514d90fd0023739cf590692b557cdfdc71997921e78732
content hash: 2f770ae9c76c2dd9bdebb85d8cade9fe92ca7bbf875ca0593113247a913854d7
signed: 2026-04-13T04:44:57.921Z
sources: 6 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf